Sundaram Multi Pap Limited Board Approves Q3 FY26 Unaudited Standalone Financial Results

1 min read     Updated on 14 Feb 2026, 02:32 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sundaram Multi Pap Limited's board of directors convened on February 14, 2026, and approved unaudited standalone financial results for Q3 FY26 and nine months ended December 31, 2025. The three-hour meeting was held at the company's Mumbai facility under Chairman & Managing Director Amrut P Shah's leadership, ensuring compliance with SEBI Regulation 33 requirements and providing stakeholders with updated financial performance data.

32605334

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited has announced the successful completion of its board meeting held on February 14, 2026, where key financial results were approved for the third quarter of fiscal year 2026. The meeting took place at the company's premises located at 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai, spanning three hours from 11:00 AM to 2:00 PM.

Board Meeting Details and Venue

The board meeting was conducted under the leadership of Chairman & Managing Director Amrut P Shah, who holds DIN 00033120. The meeting was held in compliance with regulatory requirements and followed the intimation submitted to stock exchanges on February 6, 2026.

Meeting Parameter: Details
Date: February 14, 2026
Commencement Time: 11:00 AM
Conclusion Time: 2:00 PM
Venue: 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai 400093
Presiding Officer: Amrut P Shah, Chairman & Managing Director

Financial Results Approval

The primary agenda of the board meeting focused on the consideration and approval of unaudited standalone financial results. The directors approved the financial performance data for both the quarter and nine months ended December 31, 2025, marking the completion of Q3 FY26 reporting requirements.

The financial results were prepared in accordance with applicable accounting standards and were accompanied by a Limited Review Report issued by the company's auditors. This approval ensures compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations by formally communicating the board meeting outcome to both BSE Limited and National Stock Exchange of India Limited. The communication was digitally signed by Chairman & Managing Director Amrut P Shah on February 14, 2026, at 14:09:27 +05'30', ensuring proper documentation and timestamp verification.

Exchange Details: Information
BSE Scrip Code: 533166
NSE Symbol: SUNDARAM
Regulation Reference: SEBI Regulation 33
Reporting Period: Quarter and nine months ended December 31, 2025

The approval of these unaudited standalone financial results represents a significant milestone in the company's quarterly reporting cycle, providing stakeholders with updated financial information for the third quarter and nine-month period of fiscal year 2026.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%+1.82%-4.00%-16.42%-17.65%+15.86%

Sundaram MultiPap Reports Q2 FY2026 Net Loss, Shareholders Approve Preferential Share Issue

2 min read     Updated on 13 Nov 2025, 08:31 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Sundaram Multi Pap Limited reported a net loss of Rs 83.01 lacs for Q2 FY2026, compared to a profit of Rs 44.38 lacs in Q1. Total income decreased by 36.1% to Rs 2,603.65 lacs. Shareholders approved the issuance of 7.04 crore preferential shares to acquire a 52.38% stake in Sundaram Land and Assets Private Limited. The resolution received 98.30% favorable votes at the EGM. Auditors raised concerns about trade receivables and inadequate provisions.

24591677

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited, a manufacturer of exercise notebooks and paper stationery, has reported a net loss for the quarter ended September 30, 2025, while also receiving shareholder approval for a significant preferential share issue.

Financial Performance

For the second quarter of fiscal year 2026, Sundaram MultiPap posted a net loss of Rs 83.01 lacs, a stark contrast to the net profit of Rs 44.38 lacs reported in the previous quarter. The company's total income decreased to Rs 2,603.65 lacs from Rs 4,072.31 lacs in the prior quarter.

Here's a breakdown of the key financial metrics for Q2 FY2026:

Particulars Q2 FY2026 (in lacs) Q1 FY2026 (in lacs) Change
Total Income 2,603.65 4,072.31 -36.1%
Net Profit/(Loss) (83.01) 44.38 -287.0%
EPS (Basic & Diluted) 0.02 (0.01) -

For the half-year period ended September 30, 2025, the company reported a net loss of Rs 158.28 lacs.

Operational Highlights

The company's board of directors approved the unaudited standalone financial results in a meeting held on November 13, 2025. Sundaram MultiPap primarily operates in the exercise notebook paper segment.

Shareholder Approval for Preferential Share Issue

In a separate development, shareholders of Sundaram MultiPap have approved the issuance of 7.04 crore equity shares on a preferential basis. This approval was granted during an Extraordinary General Meeting (EGM) held on November 12, 2025.

The preferential issue is aimed at non-promoter shareholders of Sundaram Land and Assets Private Limited. Through this issuance, Sundaram MultiPap plans to acquire a 52.38% stake in the target company.

EGM Voting Results

The resolution for the preferential share issue received overwhelming support from shareholders:

  • 98.30% of the total votes cast were in favor of the resolution
  • Only 1.70% of the votes were against the proposal
  • The total number of valid votes cast was 16,20,36,028

Auditor's Observations

The company's auditors have noted concerns regarding trade receivables, highlighting the need for confirmations and expressing that inadequate provisions have been made for long-outstanding receivables. This qualification was also present in the previous year's financial statements.

Looking Ahead

While Sundaram MultiPap faces challenges in its financial performance, the approved preferential share issue may provide new opportunities for growth and expansion. The company will need to address the auditor's concerns regarding trade receivables to improve its financial position and reporting quality.

Investors and stakeholders will be watching closely to see how the company navigates these challenges and capitalizes on the newly approved share issuance in the coming quarters.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
+1.20%+1.82%-4.00%-16.42%-17.65%+15.86%

More News on Sundaram Multi Pap

1 Year Returns:-17.65%